County of Monmouth, New Jersey v. Florida Cancer Specialists, P.L. et al

Track this case

Case Number:

2:18-cv-00201

Court:

Florida Middle

Nature of Suit:

Anti-Trust

Multi Party Litigation:

Class Action

Judge:

Steven D. Merryday

Firms

  1. March 18, 2020

    Robins Kaplan To Share $2.2M Fee With NJ Solo Atty

    Robins Kaplan LLP and New Jersey solo attorney Michael J. Fitzgerald reaped $2.2 million for their class counsel role in an antitrust lawsuit accusing a Florida cancer treatment center of scheming to monopolize oncology services, according to a federal judge's final approval of the suit's $7.2 million settlement deal Tuesday.

  2. June 05, 2019

    Court OKs Cancer Center's Revised $7.2M Antitrust Deal

    A Florida federal judge on Wednesday signed off on a $7.2 million settlement in a class action against a Florida cancer treatment center accused of scheming to monopolize oncology services, saying revisions to the proposed deal put to rest several concerns he raised last month.

  3. April 05, 2019

    Cancer Center's $7.2M Antitrust Deal Flawed, Court Says

    A proposed class has three weeks to justify or rework a $7.2 million settlement it reached with a Florida cancer treatment center to end claims the center hatched a plan to monopolize the market for oncology services after a Florida federal judge found the deal had a number of deficiencies, including cutting out too many potential claims.

  4. February 25, 2019

    Cancer Center, County Seek OK Of $7.2M Deal In Antitrust Suit

    A Florida cancer treatment center and a New Jersey county have urged a federal judge to approve a nearly $7.2 million settlement that would resolve claims that the center agreed to restrict competition and monopolize the market for oncology services in the southwestern part of the Sunshine State.

  5. March 28, 2018

    Fla. Cancer Centers Accused Of Illegally Dividing Up Market

    Two Florida cancer treatment centers were hit Monday with a putative class suit claiming they had an illegal agreement to restrict competition and monopolize the market for oncology services in Southwest Florida.